These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16699469)

  • 21. Hepatitis B virus infection and the dialysis patient.
    Fabrizi F; Messa P; Martin P
    Semin Dial; 2008; 21(5):440-6. PubMed ID: 18397202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Infections with hepatitis B virus in hemodialysis units of Wielkopolska].
    Grzegorzewska AE; Kurzawska-Firlej D; Swiderski A; de Mezer-Dambek M; Frankiewicz D; Zaremba-Drobnik D; Banachowicz W; Dumanowska-Zmuda A; Ratajewski W; Niepolski L; Krawczyk R; Sobolewski J; Pulchny J; Molenda J; Wojciechowski J; Mikstacki Z; Zachwieja J
    Przegl Epidemiol; 2008; 62(1):29-37. PubMed ID: 18536222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of the HBeAg/anti-HBe system in hepatitis B infection.
    Frösner GG
    Riv Emoter Immunoematol; 1980; 27(1-2):85-7. PubMed ID: 7466190
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rapid vaccination protocol against hepatitis B in patients with chronic kidney failure].
    Teruel JL; Fernández Lucas M; Mateos ML; Ortuño J
    Nefrologia; 2005; 25(3):338-9. PubMed ID: 16053018
    [No Abstract]   [Full Text] [Related]  

  • 25. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
    Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmission of hepatitis B virus from a vaccinated healthcare worker.
    Laurenson IF; Jones DG; Hallam NF; Saunders CJ; Fraser DM; Carman WF
    J Hosp Infect; 2007 Aug; 66(4):393-4. PubMed ID: 17602792
    [No Abstract]   [Full Text] [Related]  

  • 28. [Contribution of new markers to the diagnosis of hepatitis in dialysis].
    Matesanz R; Quereda C; Marcén R; Orofino L; Fernández Muñoz R; Bueno Vallejos R; González Sainz J; Ortuño J
    Rev Clin Esp; 1980 Nov; 159(3):171-5. PubMed ID: 7465895
    [No Abstract]   [Full Text] [Related]  

  • 29. [Research on antiviral antibodies of human immunodeficiency and markers of hepatitis B in polytransfused renal patients subjected to chronic hemodialysis].
    Romero MS; Lasierra P; Larrad L; Gutiérrez M
    Med Clin (Barc); 1987 May; 88(17):698-9. PubMed ID: 3649527
    [No Abstract]   [Full Text] [Related]  

  • 30. [The current aspects of the prevention of hepatitis B at hemodialysis centers (a review of the literature)].
    Novozhenov VG; Sel'kova EP; Kozhokar' IuV; Zubkin ML
    Voen Med Zh; 2000 Apr; 321(4):56-61. PubMed ID: 10860476
    [No Abstract]   [Full Text] [Related]  

  • 31. [Epidemiological characteristics of viral hepatitis B in combination with a tuberculous infection in a hospital].
    Ogarkov PI; Korotchenko SI; Tokmakov VS; Zaretskiĭ BV
    Voen Med Zh; 1996 Jul; 317(7):47-50. PubMed ID: 8967042
    [No Abstract]   [Full Text] [Related]  

  • 32. [Presence of Australia antigen and homologous antibodies in patients with acute renal failure treated by hemodialysis].
    Sandu L
    Stud Cercet Virusol; 1973; 24(5):375-9. PubMed ID: 4747457
    [No Abstract]   [Full Text] [Related]  

  • 33. [Method for the serological determination of hepatitis B antigen e].
    Kliuchareva AA; Voĭtenok NN
    Lab Delo; 1979; (10):604-6. PubMed ID: 94129
    [No Abstract]   [Full Text] [Related]  

  • 34. New hepatitis B vaccine formulated with an improved adjuvant system.
    Kundi M
    Expert Rev Vaccines; 2007 Apr; 6(2):133-40. PubMed ID: 17408363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology and prevention of "dialysis" hepatitis].
    Ermolenko VM; Vishnevskaia RK
    Ter Arkh; 1978; 50(6):134-44. PubMed ID: 79227
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of oral levamisole on immunological response to hepatitis B vaccine in haemodialysis patients.
    Alavian SM; Tabatabaei SV
    Aliment Pharmacol Ther; 2011 Jan; 33(1):160; author reply 161. PubMed ID: 21128985
    [No Abstract]   [Full Text] [Related]  

  • 37. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.
    Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J
    Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of exposure to hepatitis B and C viruses in hemodialysis patients: a 10-year survey.
    Piazza V; Montagna G; Galli F; Efficace E; Boselli E; Cristina G; Salvadeo A; Mondelli MU
    Clin Nephrol; 2001 Sep; 56(3):252-4. PubMed ID: 11597043
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute hepatitis B infection in a long-term hemodialysis patient despite persistent natural immunity.
    Ennis J; Stankus N
    Am J Kidney Dis; 2008 Nov; 52(5):978-81. PubMed ID: 18805610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [SH antigen in patients undergoing long-term extracorporal dialysis. Cross-sectional study in five German centers for hemodialysis].
    Sanwald R; Ritz E; Rapp W; Andrassy K; Kommerell B
    Dtsch Med Wochenschr; 1970 Feb; 95(6):253-6. PubMed ID: 5417676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.